129 related articles for article (PubMed ID: 26272649)
1. Estimation of the optimal number of radiotherapy fractions for breast cancer: A review of the evidence.
Wong K; Delaney GP; Barton MB
Radiother Oncol; 2015 Aug; 116(2):174-8. PubMed ID: 26272649
[TBL] [Abstract][Full Text] [Related]
2. Evidence-based optimal number of radiotherapy fractions for cancer: A useful tool to estimate radiotherapy demand.
Wong K; Delaney GP; Barton MB
Radiother Oncol; 2016 Apr; 119(1):145-9. PubMed ID: 26718152
[TBL] [Abstract][Full Text] [Related]
3. An evidence-based estimation of local control and survival benefit of radiotherapy for breast cancer.
Shafiq J; Delaney G; Barton MB
Radiother Oncol; 2007 Jul; 84(1):11-7. PubMed ID: 17399830
[TBL] [Abstract][Full Text] [Related]
4. DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy.
Sautter-Bihl ML; Budach W; Dunst J; Feyer P; Haase W; Harms W; Sedlmayer F; Souchon R; Wenz F; Sauer R; ;
Strahlenther Onkol; 2007 Dec; 183(12):661-6. PubMed ID: 18040609
[TBL] [Abstract][Full Text] [Related]
5. Five year outcome of 145 patients with ductal carcinoma in situ (DCIS) after accelerated breast radiotherapy.
Ciervide R; Dhage S; Guth A; Shapiro RL; Axelrod DM; Roses DF; Formenti SC
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e159-64. PubMed ID: 22579378
[TBL] [Abstract][Full Text] [Related]
6. Estimation of an optimal chemotherapy utilisation rate for cancer: setting an evidence-based benchmark for quality cancer care.
Jacob SA; Ng WL; Do V
Clin Oncol (R Coll Radiol); 2015 Feb; 27(2):77-82. PubMed ID: 25455844
[TBL] [Abstract][Full Text] [Related]
7. [Radiotherapy of breast cancer].
Hennequin C; Barillot I; Azria D; Belkacémi Y; Bollet M; Chauvet B; Cowen D; Cutuli B; Fourquet A; Hannoun-Lévi JM; Leblanc M; Mahé MA
Cancer Radiother; 2016 Sep; 20 Suppl():S139-46. PubMed ID: 27522187
[TBL] [Abstract][Full Text] [Related]
8. The Malthus Programme: developing radiotherapy demand models for breast and prostate cancer at the local, regional and national level.
Round C; Mee T; Kirkby NF; Cooper T; Williams MV; Jena R
Clin Oncol (R Coll Radiol); 2013 Sep; 25(9):538-45. PubMed ID: 23791157
[TBL] [Abstract][Full Text] [Related]
9. Two different hypofractionated breast radiotherapy schedules for 113 patients with ductal carcinoma in situ: preliminary results.
Guenzi M; Giannelli F; Bosetti D; Blandino G; Milanese ML; Pupillo F; Corvò R; Fozza A
Anticancer Res; 2013 Aug; 33(8):3503-7. PubMed ID: 23898126
[TBL] [Abstract][Full Text] [Related]
10. Estimation of an optimal chemotherapy utilisation rate for breast cancer: setting an evidence-based benchmark for the best-quality cancer care.
Ng W; Delaney GP; Jacob S; Barton MB
Eur J Cancer; 2010 Mar; 46(4):703-12. PubMed ID: 20034784
[TBL] [Abstract][Full Text] [Related]
11. Estimation of an optimal radiotherapy utilization rate for breast carcinoma: a review of the evidence.
Delaney G; Barton M; Jacob S
Cancer; 2003 Nov; 98(9):1977-86. PubMed ID: 14584082
[TBL] [Abstract][Full Text] [Related]
12. Impact of hypofractionation and tangential beam IMRT on the acute skin reaction in adjuvant breast cancer radiotherapy.
Rudat V; Nour A; Ghaida SA; Alaradi A
Radiat Oncol; 2016 Jul; 11():100. PubMed ID: 27473272
[TBL] [Abstract][Full Text] [Related]
13. Estimation of an evidence-based benchmark for the optimal endocrine therapy utilization rate in breast cancer.
Fong A; Ng W; Barton MB; Delaney GP
Breast; 2010 Oct; 19(5):345-9. PubMed ID: 20223666
[TBL] [Abstract][Full Text] [Related]
14. A topology-based method to mitigate the dosimetric uncertainty caused by the positional variation of the boost volume in breast conservative radiotherapy.
Lee PY; Lin CY; Chen SW; Chien CR; Chu CN; Hsu HT; Liang JA; Lin YJ; Shiau AC
Radiat Oncol; 2017 Mar; 12(1):55. PubMed ID: 28320428
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionation Is an Acceptable Alternative to Conventional Fractionation in the Treatment of Postlumpectomy Ductal Carcinoma In Situ With Radiotherapy.
Isfahanian N; Al-Hajri T; Marginean H; Chang L; Caudrelier JM
Clin Breast Cancer; 2017 Apr; 17(2):e77-e85. PubMed ID: 27889437
[TBL] [Abstract][Full Text] [Related]
16. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.
Shaitelman SF; Schlembach PJ; Arzu I; Ballo M; Bloom ES; Buchholz D; Chronowski GM; Dvorak T; Grade E; Hoffman KE; Kelly P; Ludwig M; Perkins GH; Reed V; Shah S; Stauder MC; Strom EA; Tereffe W; Woodward WA; Ensor J; Baumann D; Thompson AM; Amaya D; Davis T; Guerra W; Hamblin L; Hortobagyi G; Hunt KK; Buchholz TA; Smith BD
JAMA Oncol; 2015 Oct; 1(7):931-41. PubMed ID: 26247543
[TBL] [Abstract][Full Text] [Related]
17. Accelerated hypofractionated breast radiotherapy: FAQs (frequently asked questions) and facts.
Montero A; Sanz X; Hernanz R; Cabrera D; Arenas M; Bayo E; Moreno F; Algara M
Breast; 2014 Aug; 23(4):299-309. PubMed ID: 24530095
[TBL] [Abstract][Full Text] [Related]
18. Estimating radiotherapy demands in South East Asia countries in 2025 and 2035 using evidence-based optimal radiotherapy fractions.
Yahya N; Roslan N
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e543-e547. PubMed ID: 29316293
[TBL] [Abstract][Full Text] [Related]
19. A comparison of surgical and radiotherapy breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapy.
Fong A; Shafiq J; Saunders C; Thompson AM; Tyldesley S; Olivotto IA; Barton MB; Dewar JA; Jacob S; Ng W; Speers C; Delaney GP
Breast; 2012 Aug; 21(4):570-7. PubMed ID: 22425535
[TBL] [Abstract][Full Text] [Related]
20. Estimation of an optimal radiotherapy utilization rate for gastrointestinal carcinoma: a review of the evidence.
Delaney G; Barton M; Jacob S
Cancer; 2004 Aug; 101(4):657-70. PubMed ID: 15305395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
